CHOICE-MI
CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry
AI Description
This multinational, investigator-initiated registry aims to investigate clinical outcomes of patients undergoing transcatheter mitral valve replacement (TMVR). The registry primarily focuses on patients treated with TMVR in real-world clinical practice.
Patients evaluated for TMVR but not undergoing the procedure are no longer systematically included. Historical data may include such patients who subsequently underwent alternative treatments, including transcatheter edge-to-edge repair, mitral valve surgery, or medical/conservative therapy.
- Who can join
- adult, older adult
- Participants
- 1000
- Expected completion
- 2030-12-31
- Funded by
- other
Conditions studied
Mitral Annular Calcification, Mitral Regurgitation, Mitral Valve Disease
What it measures
- Freedom from device-related complications, 30 days
- Mitral insufficiency grade 2+ or more, Mitral insufficiency measured by transthoracic echocardiography. Assessment of MI severity according to current guidelines (ESC/EACTS and ACC/AHA) for valvular heart disease., 12 months
Working with
Montreal Heart Institute, University Hospital, Bordeaux
Centers Participating
These centers are participating in this study. Reach out to them directly to learn more.
Tampa General Hospital
Tampa, FL
Abbott Northwestern Hospital
Minneapolis, MN
Brigham and Women's Hospital
Boston, MA
Cedars-Sinai Medical Center
Los Angeles, CA
Houston Methodist Hospital
Houston, TX
Montefiore Einstein Hospital (Moses Campus)
Bronx, NY
Morristown Medical Center
Morristown, NJ
Oklahoma Heart Hospital (Oklahoma City)
Oklahoma City, OK
Tucson Medical Center
Tucson, AZ
Registry entry updated 2026-05-07
Deciding whether to join a study is your choice, and you can ask a study team questions before you decide anything.
If you would rather we did it with you, call us on (656) 206-4686.